Cvi Holdings, LLC Bio Line Rx Ltd. Call Options Transaction History
Cvi Holdings, LLC
- $11.5 Million
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BLRX
# of Institutions
38Shares Held
3.32MCall Options Held
46.5KPut Options Held
6.3K-
Alyeska Investment Group, L.P. Chicago, IL866KShares$372,5920.0% of portfolio
-
Envestnet Asset Management Inc239KShares$102,8490.0% of portfolio
-
Morgan Stanley New York, NY198KShares$84,9400.0% of portfolio
-
Values First Advisors, Inc.198KShares$84,9310.06% of portfolio
-
Atria Investments LLC Charlotte, NC134KShares$57,6080.0% of portfolio
About BioLineRx Ltd.
- Ticker BLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,524,500
- Market Cap $26.5M
- Description
- BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials ...